Study on a non-invasive swallowable device for weight loss and obesity-related comorbidities in overweight and obese patients

niversity of Rome - La Sapienza (Italy)0 个研究点目标入组 200 人开始时间: 2013年10月14日最近更新: 2015年1月13日

试验速览

暂无简介。

•1. Anatomical abnormalities of the upper gastrointestinal (GI) tract
•2. Functional disorders of the upper GI tract
•3. Inflammatory and other pathophysiological conditions of the GI tract
•4. Chronic or acute use of medications known to affect integrity of the GI tract and/or weight
•5. Prior GI tract surgeries excluding uncomplicated appendectomies
•6. Untreated hypothyroidism or untreated Cushing?s disease or syndrome
•7. Severe, unstable/uncontrolled medical conditions of major organ systems
•8. Alcohol and/or illicit drugs abuse
•9. Undergoing chronic steroid or immunosuppressive therapy
•10. Pregnant or breastfeeding or intention of becoming pregnant during the study
•11. Have type 1 diabetes mellitus
•12. Must not undertake scuba diving or travel in an unpressurized airplane cabin
•13. Known allergies to products/foods of porcine origin
•14. Untreated Heliocobacter pylori infection

发起方

niversity of Rome - La Sapienza (Italy)